Heimdall Insights

Global Erectile Dysfunction Drugs Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Erectile Dysfunction Drugs Market was valued at $3.9 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.4% CAGR, to an estimated market size of $5.8 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global erectile dysfunction (ED) drugs market comprises pharmaceutical treatments, primarily phosphodiesterase type 5 (PDE5) inhibitors, designed to address the persistent inability to achieve or maintain an erection. The scope includes branded and generic medications administered via oral, injectable, and topical routes, while excluding surgical implants and vacuum therapy devices.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Erectile Dysfunction Drugs Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Segments

  • Oral Medications
  • Injectable Treatments
  • Topical Gels and Others